Halozyme ($HALO) podcast mentions

Name: $HALO podcast mentions
Creator: Ticker.id
License: https://ticker.id/data-license

Per Ticker.id: 2 Halozyme ($HALO) mentions across 1 podcast (30 days) — timestamped, verifiable quotes, updated 2026-10-02.

So Halozyme Therapeutics is a biopharma company. Um, so they are a biopharma royalty company as well as a drug delivery company. They've done really well, uh, going back to 2020, really. I mean, relative strength versus the S&P is solid. They're up 63% year to date. They're up 53% over the past 52 weeks.
Luke Guerrero · InvestTalk · Wall Street Is Back in Charge: What Institutional Money Flowing Into Markets Means for Retail Investors · 2026-10-02